Warning: Illegal string offset 'name' in /homepages/29/d231077926/htdocs/review/wp-content/plugins/genesis-simple-sidebars/plugin.php on line 105

Warning: Illegal string offset 'description' in /homepages/29/d231077926/htdocs/review/wp-content/plugins/genesis-simple-sidebars/plugin.php on line 107
Augmenix Announces First Commercial Use of SpaceOAR™ System — Augmenix

Augmenix Announces First Commercial Use of SpaceOAR™ System

Augmenix Announces First Commercial Use of SpaceOAR™ System for Prostate-Rectum Separation in Prostate Cancer Patients Undergoing Radiation Therapy

WALTHAM, Mass., Aug. 11 /PRNewswire/ — Augmenix, Inc. announced today that Prof. Michael Eble and Dr. Michael Pinkawa of the Aachen University Hospital, Aachen, Germany, performed a commercial implantation of the company’s CE Mark approved SpaceOAR™ System. The SpaceOAR hydrogel (from spacing Organs At Risk) is designed to be a tissue compatible, absorbable spacer to reduce radiation injury to healthy tissues.

View entire article…